Pal S - Search Results

1

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.

Kwiatkowski DJ, Choueiri TK, Fay AP, Rini BI, Thorner AR, de Velasco G, Tyburczy ME, Hamieh L, Albiges L, Agarwal N, Ho TH, Song J, Pignon JC, Barrios PM, Michaelson MD, Van Allen E, Krajewski KM, Porta C, Pal S, Bellmunt J, McDermott DF, Heng DYC, Gray KP, Signoretti S. Kwiatkowski DJ, et al. Among authors: pal s. Clin Cancer Res. 2016 May 15;22(10):2445-2452. doi: 10.1158/1078-0432.CCR-15-2631. Epub 2016 Feb 1. Clin Cancer Res. 2016. PMID: 26831717 Free PMC article.

2

The role of targeting mammalian target of rapamycin in lung cancer.

Pal SK, Figlin RA, Reckamp KL. Pal SK, et al. Clin Lung Cancer. 2008 Nov;9(6):340-5. doi: 10.3816/CLC.2008.n.049. Clin Lung Cancer. 2008. PMID: 19073516 Review.

3

Targeted therapies for renal cell carcinoma: understanding their impact on survival.

Pal SK, Figlin RA. Pal SK, et al. Target Oncol. 2010 Jun;5(2):131-8. doi: 10.1007/s11523-010-0145-6. Epub 2010 Jul 15. Target Oncol. 2010. PMID: 20632214 Review.

4

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma.

Pal SK, Figlin RA. Pal SK, et al. Target Oncol. 2011 Mar;6(1):5-16. doi: 10.1007/s11523-011-0172-y. Epub 2011 Apr 12. Target Oncol. 2011. PMID: 21484496 Free PMC article. Review.

5

New therapies for castrate-resistant prostate cancer.

Williams SB, Lay AH, Lau CS, Josephson DY, Wilson TG, Choueiri TK, Pal SK. Williams SB, et al. Among authors: pal sk. Expert Opin Pharmacother. 2011 Sep;12(13):2069-74. doi: 10.1517/14656566.2011.590133. Epub 2011 Jun 11. Expert Opin Pharmacother. 2011. PMID: 21663529 Review.

6

Systemic therapies for metastatic renal cell carcinoma in older adults.

Pal SK, Vanderwalde A, Hurria A, Figlin RA. Pal SK, et al. Drugs Aging. 2011 Aug 1;28(8):635-49. doi: 10.2165/11592880-000000000-00000. Drugs Aging. 2011. PMID: 21812499 Free PMC article. Review.

7

Managing refractory metastatic renal cell carcinoma: a RECORD spinning on a tilted AXIS.

Pal SK, Vogelzang NJ. Pal SK, et al. Clin Genitourin Cancer. 2011 Sep;9(1):3-5. doi: 10.1016/j.clgc.2011.06.003. Epub 2011 Aug 3. Clin Genitourin Cancer. 2011. PMID: 21816688 No abstract available.

8

Role of surgery for locally advanced and metastatic renal cell carcinoma.

Torrey R, Spiess PE, Pal SK, Josephson D. Torrey R, et al. J Natl Compr Canc Netw. 2011 Sep 1;9(9):985-93. doi: 10.6004/jnccn.2011.0083. J Natl Compr Canc Netw. 2011. PMID: 21917623 Review.

9

Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.

Xin H, Herrmann A, Reckamp K, Zhang W, Pal S, Hedvat M, Zhang C, Liang W, Scuto A, Weng S, Morosini D, Cao ZA, Zinda M, Figlin R, Huszar D, Jove R, Yu H. Xin H, et al. Among authors: pal s. Cancer Res. 2011 Nov 1;71(21):6601-10. doi: 10.1158/0008-5472.CAN-11-1217. Epub 2011 Sep 15. Cancer Res. 2011. PMID: 21920898 Free PMC article.

10

Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm.

Pal SK, Williams S, Josephson DY, Carmichael C, Vogelzang NJ, Quinn DI. Pal SK, et al. Mol Cancer Ther. 2012 Mar;11(3):526-37. doi: 10.1158/1535-7163.MCT-11-0806. Epub 2012 Feb 17. Mol Cancer Ther. 2012. PMID: 22351744 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,663 results

Search Page

Filters